Sonia Victoria Del Rincón

8PUBLICATIONS

75CO-AUTHORS

Medical virologyMolecular targetsRespiratory diseasesCancer diagnosisMedical robotics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|May 06, 2026

mTOR inhibition enhances the antitumor efficacy of pan-RAF-MEK blockade by inhibiting the ATF4-MTHFD2 pathway.

|Feb 18, 2026

RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR.

Raúl E Flores-González, Christophe Goncalves, Noah Wirasinghe

|Dec 29, 2025

The CCL17-CCR4 Axis Is Critical for Mutant STAT6-Mediated Microenvironmental Remodeling and Therapeutic Resistance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.

Madelyn J Abraham, Cynthia Guilbert, Natascha Gagnon

|Dec 26, 2024

Clinical Proteomics Reveals Vulnerabilities in Noninvasive Breast Ductal Carcinoma and Drives Personalized Treatment Strategies.

Georgia Mitsa, Livia Florianova, Josiane Lafleur

|Nov 22, 2024

Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer.

Cristiano Ferrario, John Mackey, Karen A Gelmon

|Sep 13, 2024

Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis.

Samuel E J Preston, Michael S Dahabieh, Raúl Ernesto Flores González

Pageof 2

Frequent Collaborators

Wilson H Miller

Samuel Preston

Elizabeth M Guettler

Christoph H Borchers

Fan Huang

Christophe Gonçalves

Vincent R Richard

April A N Rose

Rene P Zahedi

Natascha Gagnon

Frequent Collaborators

Wilson H Miller

Samuel Preston

Elizabeth M Guettler

Christoph H Borchers